Thus, pulsing target cells with the inhibitor compounds induced the truncated cancer-associated O-glycan Tn29,63, which triggered ADCC activity by mAbs directed to Tn-glycopeptide epitopes in MUC1 and FXYD5 (Fig. 6c). The gene discussed is FXYD5; the disease is cancer.